chartexchange

TSHA
Taysha Gene Therapies, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:34:01 AM EST
4.07USD+2.005%(+0.08)128,388
4.0500Bid4.0900Ask0.0400Spread

TSHA Financials

In Q3 FY 2026 (ended ), Taysha Gene Therapies, Inc. Common Stock (TSHA) reported revenue of $0, net income of −$39.13M, operating cash flow of −$32.91M, and assets of $435.03M (filed ).

Loading financial statements…